Correspondence  |   February 1995
Measurement of Cerebral Blood Flow during Hypothermic Cardiopulmonary Bypass
Author Notes
  • David J. Cook, M.D., Assistant Professor Anesthesiology, John D. Michenfelder, M.D., Emeritus Professor of Anesthesiology, Mayo Medical School, Mayo Clinic, Rochester, Minnesota 55905.
Article Information
Correspondence   |   February 1995
Measurement of Cerebral Blood Flow during Hypothermic Cardiopulmonary Bypass
Anesthesiology 2 1995, Vol.82, 604. doi:
Anesthesiology 2 1995, Vol.82, 604. doi:
To the Editor:—In our opinion, two related issues in the article by Ohsumi et al. [1 ] need to be addressed. The cerebral blood flows (CBF) and metabolic rates for oxygen (CMRO2) they report using the Kety-Schmidt technique are appropriate and similar to reports by our laboratory [2 ] and that of Stephan et al., [3 ] with the exception of the CBF (19 ml *symbol* 100 g sup -1 *symbol* min sup -1) they document during hypothermic cardiopulmonary bypass. During hypothermia, the patients in the study were significantly hypocarbie (mean PaCO2= 29.7 mmHg). This degree of hypocarbia will decrease CBF by approximately 25–30% in the context of a opioid-benzodiazepine anesthesia. [4,5 ] Correcting for this hypocarbia, the CBF under normocarbic conditions (with alpha-stat management and hypothermia) would be closer to 25 ml *symbol* 100 g sup -1 *symbol* min sup -1. This value is similar to what our laboratory [2 ] and that of Stephan et al. [3 ] reported.
Second, and more importantly, Ohsumi et al. sell the Kety-Schmidt method short when comparing their results to those previously obtained with133Xenon clearance. [6,7 ] Ohsumi et al. suggest in their discussion that the CBF and CMRO2values they report are too high when compared to values reported with the133Xenon method. We would argue that the133Xenon values typically reported are too low, and the Ohsumi et al. values are correct. [2 ] The Ohsumi et al. Kety-Schmidt-derived CBF and CMRO2values are consistent with theoretical predictions and direct measurements in animals, unlike those commonly reported with133Xenon.
David J. Cook, M.D.; Assistant Professor Anesthesiology; John D. Michenfelder, M.D.; Emeritus Professor of Anesthesiology; Mayo Medical School; Mayo Clinic; Rochester, Minnesota 55905.
(Accepted for publication November 10, 1994.)
Ohsumi H, Kitaguchi K, Nakajima T, Ohnishi Y, Kuro M: Internal jugular bulb blood velocity as a continuous indicator of cerebral blood flow during open heart surgery. ANESTHESIOLOGY 81:325-332, 1994.
Cook DJ, Anderson RE, Michenfelder JD, Oliver WC Jr, Orszulak TA, Daly RC, Bryce RD: Cerebral blood flow during cardiac surgery: Comparison of the Kety-Schmidt and sup 133 Xenon clearance methods. Ann Thorac Surg (in press).
Stephan H. Weyland A, Kazmaier S, Henze T, Menck S, Sonntag H: Acid-base management during hypothermic cardiopulmonary bypass does not affect cerebral metabolic but does affect blood flow and neurological outcome. Br J Anaesth 69:51-57, 1992.
Forster A, Juge O, Morel D: Effects of midazolam on cerebral hemodynamics and cerebral vasomotor responsiveness to carbon dioxide. J Cereb Blood Flow Metab 3:246-249, 1983.
McPherson RW, Traystman RJ: Fentanyl and cerebral vascular responsivity in dogs. ANESTHESIOLOGY 60:180-186, 1984.
Murkin JM, Farrar JK, Tweed WA, McKenzie FN, Guiraudon G: Cerebral autoregulation and flow/metabolism coupling during cardiopulmonary bypass: The influence of PaCO sub 2. Anesth Analg 66:825-832, 1987.
Croughwell N, Smith LR, Quill T, Newman M, Greeley W, Kern F, Lu J, Reves JG: The effect of temperature on cerebral metabolism and blood flow in adults during cardiopulmonary bypass. J Thorac Cardiovasc Surg 103:549-554, 1992.